Proportion of Immunoregulatory Cells in Inflammatory Infiltrate in Rheumatoid Arthritis Model and Its Correction by Antisense Oligonucleotides.

IF 0.9 4区 医学 Q4 MEDICINE, RESEARCH & EXPERIMENTAL
T P Makalish, N N Pilyavskiy, I O Golovkin, G V Maslova
{"title":"Proportion of Immunoregulatory Cells in Inflammatory Infiltrate in Rheumatoid Arthritis Model and Its Correction by Antisense Oligonucleotides.","authors":"T P Makalish, N N Pilyavskiy, I O Golovkin, G V Maslova","doi":"10.1007/s10517-025-06407-w","DOIUrl":null,"url":null,"abstract":"<p><p>Autoimmune inflammation in rheumatoid arthritis is caused by various immunocompetent cells secreting a wide range of cytokines. Macrophages, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells are the most active in this process. We propose using antisense oligonucleotides (ASO) that block the synthesis of TNFα and IL-6. In the adjuvant-induced arthritis model, changes in the number of CD4<sup>+</sup>, CD8<sup>+</sup>, and CD68<sup>+</sup> cells in the inflammatory infiltrate after correction with ASO were assessed. The number of immunopositive inflammatory infiltrate cells in the area of bone damage was counted. CD8<sup>+</sup> cells turned out to be the most numerous. Blockade of IL-6 led to a statistically significant decrease in the number of CD4<sup>+</sup> cells. The use of ASO reduced the number of macrophages. The combination of ASO against IL-6 and TNFα administered by electrophoresis most effective.</p>","PeriodicalId":9331,"journal":{"name":"Bulletin of Experimental Biology and Medicine","volume":" ","pages":"733-738"},"PeriodicalIF":0.9000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bulletin of Experimental Biology and Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s10517-025-06407-w","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/5/30 0:00:00","PubModel":"Epub","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

Autoimmune inflammation in rheumatoid arthritis is caused by various immunocompetent cells secreting a wide range of cytokines. Macrophages, CD4+, and CD8+ T cells are the most active in this process. We propose using antisense oligonucleotides (ASO) that block the synthesis of TNFα and IL-6. In the adjuvant-induced arthritis model, changes in the number of CD4+, CD8+, and CD68+ cells in the inflammatory infiltrate after correction with ASO were assessed. The number of immunopositive inflammatory infiltrate cells in the area of bone damage was counted. CD8+ cells turned out to be the most numerous. Blockade of IL-6 led to a statistically significant decrease in the number of CD4+ cells. The use of ASO reduced the number of macrophages. The combination of ASO against IL-6 and TNFα administered by electrophoresis most effective.

类风湿关节炎模型炎症浸润免疫调节细胞比例及其反义寡核苷酸校正。
类风湿性关节炎的自身免疫性炎症是由多种免疫活性细胞分泌多种细胞因子引起的。巨噬细胞、CD4+和CD8+ T细胞在这一过程中最为活跃。我们建议使用反义寡核苷酸(ASO)来阻断TNFα和IL-6的合成。在佐剂诱导的关节炎模型中,评估ASO校正后炎症浸润中CD4+、CD8+和CD68+细胞数量的变化。计数骨损伤区免疫阳性炎症浸润细胞的数量。CD8+细胞数量最多。阻断IL-6导致CD4+细胞数量显著减少。ASO的使用减少了巨噬细胞的数量。电泳给药时,ASO联合使用对IL-6和tnf - α最有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Bulletin of Experimental Biology and Medicine
Bulletin of Experimental Biology and Medicine 医学-医学:研究与实验
CiteScore
1.50
自引率
14.30%
发文量
265
审稿时长
2 months
期刊介绍: Bulletin of Experimental Biology and Medicine presents original peer reviewed research papers and brief reports on priority new research results in physiology, biochemistry, biophysics, pharmacology, immunology, microbiology, genetics, oncology, etc. Novel trends in science are covered in new sections of the journal - Biogerontology and Human Ecology - that first appeared in 2005. World scientific interest in stem cells prompted inclusion into Bulletin of Experimental Biology and Medicine a quarterly scientific journal Cell Technologies in Biology and Medicine (a new Russian Academy of Medical Sciences publication since 2005). It publishes only original papers from the leading research institutions on molecular biology of stem and progenitor cells, stem cell as the basis of gene therapy, molecular language of cell-to-cell communication, cytokines, chemokines, growth and other factors, pilot projects on clinical use of stem and progenitor cells. The Russian Volume Year is published in English from April.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信